|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
1313 N Market St,Wilmington,Delaware,US
|
|
Ayala Pharmaceuticals | 1,238 followers on LinkedIn. Clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for rare cancers. | Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Our differentiated development approach is predicated on identifying and addressing tumorigenic drivers of cancer, through a combination of our bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations.
The company’s product candidates, AL101 and AL102, were licensed into Ayala from Bristol Myers Squibb.
|
Ayala Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Ayala Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Ayala Pharmaceuticals customer service number in your country click here to find.
Roni Mamluk is the CEO of Ayala Pharmaceuticals. To contact Roni Mamluk email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.